AstraZeneca $3 billion 3.50%, 4%, 4.375%, floating rate notes issue

14/8/2018
Investment grade bond/note issue

$ 3 billion

Announced

14/8/2018


Overview:

  • The issue consists of $850 million 3.50% notes due 2023, $400 million floating rate notes due 2023, $1 billion 4% notes due 2029 and $750 million 4.375% notes due 2048.
  • AstraZeneca is a global biopharmaceutical company.

Mihail Georgiev - Data analyst

Jurisdictions:

United States
United Kingdom

Deal type:

Investment grade bond/note issue

Practice area:

Capital markets : Debt

Governing laws:

New York
England and Wales
United States

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: AstraZeneca (Issuer)


Party: AstraZeneca (Issuer)